Research and Markets: 2015-2019 UK Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

Research and Markets (http://www.researchandmarkets.com/research/5ngggl/20152019_uk) has announced the addition of the "2015-2019 UK Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering.

The report is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. It examines trends in the UK cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field.

Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Scope of the report:

Business Opportunities and Strategic Recommendations:

• Specific new product development opportunities with potentially significant market appeal during the next five years.
• Design criteria for new products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Market Segmentation Analysis:

• Sales and market shares of major suppliers, by individual cancer diagnostic test.
• Five-year test volume and sales forecasts for major cancer diagnostic tests by market segment, including:
• Hospitals
• Commercial/Private Laboratories

Market segmentation analysis:

• Review of the market dynamics
• Structure
• Size,
  
• Growth
  
• Major suppliers.

A review of over 200 current and emerging cancer diagnostic tests, including:

• Biochemical Markers
• Oncogenes
• Growth Factors
• Hormones
• Colony Stimulating Factors
• Lymphokines
• Immunohistochemical Stains, and others.

Technology Review:

• Assessment of monoclonal antibodies
• Immunoassays,
  
• DNA probes,
  
• Biochips/microarrays,
  
• Chromosome analysis,
  
• IT,
  
• Artificial intelligence,
  
• Flow cytometry,
  
• Biosensors
  
• Other technologies and their potential applications for cancer diagnostic testing.
  

Review of competing/complementing technologies, including:

• CT,
• MRI,
• NMR,
  
• PET
  
• Photonics spectroscopy.

Strategic assessments of major suppliers and start-up firms, including their:

• Sales,
  Product portfolios,
  
• Marketing tactics,
  
• Collaborative arrangements,
  
• New products in R&D.

It also includes an extensive list of over 500 companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

For more information visit http://www.researchandmarkets.com/research/5ngggl/20152019_uk

View source version on businesswire.com: http://www.businesswire.com/news/home/20151126005072/en/